Related Experiment Video
Updated: Jan 12, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Global lncRNA expression profiles in medulloblastoma reveal crucial lncRNA-oncogene interactions in Sonic hedgehog
Iván Martínez de Estíbariz1, Unai Illarregi1, Daniel Sinnett2,3
1Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain.
Background:
Advances in multi-omic studies have improved medulloblastoma (MB) characterization, yet novel molecular biomarkers are needed to refine tumor biology and therapeutic strategies. Current profiling mainly targets the protein-coding genome, while the potential of noncoding regions remains unexplored. This study aims to identify long noncoding RNAs (lncRNAs), emerging as crucial regulators in MB, as potential key biomarkers specific to molecular group, enhancing understanding of MB's genomic landscape.
Methods:
RNA-seq data from 54 Spanish MB patients (C1) and 207 public samples (C2) were analyzed to profile lncRNAs. Expression and Weighted Gene Coexpression Network (WGCNA) analyses were performed to identify lncRNA-oncogene interactions. Group-specific interactions were examined to infer their role in MB pathogenesis and highlight potential lncRNA involvement in disease mechanisms.
Results:
LncRNA expression profiles identified 4 clusters corresponding to the MB molecular groups, confirming their potential as biomarkers. Expression and WGCNA analyses revealed group-specific lncRNAs for Sonic hedgehog (SHH), Group 3 (Gr3), and Group 4 (Gr4) MB. Lnc-SMARCA2 was exclusively upregulated in SHH MB, and associated with ATOH1 and PDLIM3, key cilium regulators of this group's cell of origin. In Gr4 MB, MGC32805 and LOC107986446 were upregulated and linked to SNCAIP, potentially influencing PRDM6 activation via enhancer hijacking. Additionally, a 5-lncRNA signature linked to phototransduction was exclusive to Gr3, offering insights into its lineage switch and molecular regulation.
Conclusions:
Lnc-SMARCA2 and, MGC32805 and LOC107986446, are exclusively deregulated in SHH and Gr4 MB, respectively, and directly associated with group-specific MB oncogenes, representing promising novel biomarkers and therapeutic targets in MB.
Insights
This study identifies specific long noncoding RNAs (lncRNAs) as potential biomarkers for medulloblastoma (MB) molecular groups. These lncRNAs, including Lnc-SMARCA2, MGC32805, and LOC107986446, are linked to specific MB subtypes and oncogenes, offering new therapeutic targets.
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Background:
- Medulloblastoma (MB) characterization is improving with multi-omic studies, but novel molecular biomarkers are needed.
- Current profiling focuses on the protein-coding genome, leaving noncoding regions unexplored.
- Long noncoding RNAs (lncRNAs) are emerging as crucial regulators in MB and potential key biomarkers.
Purpose of the Study:
- To identify lncRNAs specific to MB molecular groups.
- To explore the role of lncRNAs in MB pathogenesis and disease mechanisms.
- To enhance understanding of MB's genomic landscape through noncoding region analysis.
Main Methods:
- RNA-sequencing (RNA-seq) data from 261 MB patients (54 Spanish, 207 public).
- Expression analysis and Weighted Gene Coexpression Network (WGCNA) to identify lncRNA-oncogene interactions.
- Examination of group-specific interactions to infer pathogenic roles.
Main Results:
- LncRNA expression profiles identified 4 clusters corresponding to MB molecular groups.
- Group-specific lncRNAs were found for Sonic hedgehog (SHH), Group 3 (Gr3), and Group 4 (Gr4) MB.
- Lnc-SMARCA2 (SHH), MGC32805/LOC107986446 (Gr4), and a 5-lncRNA signature (Gr3) were identified and linked to specific oncogenes and pathways.
Conclusions:
- Lnc-SMARCA2, MGC32805, and LOC107986446 are exclusively deregulated in SHH and Gr4 MB, respectively.
- These lncRNAs are associated with group-specific MB oncogenes, indicating their role in pathogenesis.
- These findings highlight promising novel biomarkers and therapeutic targets for MB treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Hedgehog Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

